Anaptysbio (ANAB) Asset Utilization Ratio (2017 - 2026)

Anaptysbio (ANAB) posted Asset Utilization Ratio of 0.5 for Q1 2026, up 2.07% on a QoQ basis from 0.49 in Q4 2025, and up 186.45% year-over-year from 0.17 in Q1 2025.

Anaptysbio (ANAB) Asset Utilization Ratio (2017 - 2026) Analysis & Trends

Anaptysbio's Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.5 for Q1 2026.

  • Quarterly Asset Utilization Ratio rose 186.45% year-over-year to 0.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.5 (up 186.45% YoY) and the FY2025 annual result came in at 0.55, up 183.68% from the prior year.
  • Asset Utilization Ratio was 0.5 for Q1 2026 at Anaptysbio, up from 0.49 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.5 in Q1 2026 and bottomed at 0.01 in Q3 2022.
  • A 5-year average of 0.14 and a median of 0.07 in 2022 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2022 — Asset Utilization Ratio tumbled 97.16% — and 2025, when it surged 309.98%.
  • Anaptysbio's Asset Utilization Ratio stood at 0.01 in 2022, then surged by 164.61% to 0.04 in 2023, then soared by 225.91% to 0.12 in 2024, then jumped by 309.98% to 0.49 in 2025, then gained by 2.07% to 0.5 in 2026.
  • Business Quant data shows ANAB's Asset Utilization Ratio at 0.5 in Q1 2026, 0.49 in Q4 2025, and 0.36 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.69
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 0.37
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Anaptysbio 1.55 Bn 1.27 Bn - 0.50

Historic Data

Download Data
DateValue
Mar 31, 2026 0.50
Dec 31, 2025 0.49
Sep 30, 2025 0.36
Jun 30, 2025 0.24
Mar 31, 2025 0.17
Dec 31, 2024 0.12
Sep 30, 2024 0.09
Jun 30, 2024 0.07
Mar 31, 2024 0.05
Dec 31, 2023 0.04
Sep 30, 2023 0.03
Jun 30, 2023 0.02
Mar 31, 2023 0.02
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.04
Mar 31, 2022 0.07
Dec 31, 2021 0.10
Sep 30, 2021 0.26
Jun 30, 2021 0.22